Pharmaxis Ltd

Pharmaxis Ltd

Pharmaxis has an ax to grind with chronic respiratory and autoimmune diseases. The Australian company researches, develops, and markets therapeutic pharmaceutical products to combat these and other illnesses. Pharmaxis has received approval to market asthma treatment Aridol in select regions. The company has research and development programs for additional disease targets such as cystic fibrosis, chronic obstructive pulmonary disease, bronchiectasis, and pulmonary fibrosis. Pharmaxis acquired respiratory therapeutics developer TOPIGEN Pharmaceuticals in 2010, adding to Pharmaxis' roster of potential treatments for respiratory disorders including asthma and COPD.

Contact Details

Office Address

Pharmaxis Ltd
20 Rodborough Road
Frenchs Forest, NSW, Australia 2086
Phone: +61-2-9454-7200
Fax: +61-2-9451-3622

Executives

Chairman

Denis M. Hanley

CEO and Managing Director

Alan D. Robertson

Business Reviews for Pharmaxis Ltd

Related Companies